logo

For the Inventor, By the Inventor

Birmingham, AL, United States of America

Glynn P Wheeler

This inventor holds 6 USPTO granted patents. Top assignee: Southern Research Institute. Active years: 1984-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glynn P Wheeler. Retrieved from https://idiyas.com/inventor/glynn-p-wheeler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal6 out of 205 
 
Southern Research Institute
 patents

Years Active: 1984-1990

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4892874 - Synergistic anticancer combination (1990-01-09),
2. 4645840 - Intermediates for preparing 1,2-dihydropyrido[3,4-b]-pyrazines (1987-02-24),
3. 4600716 - 1,2-dihydropyrido[3,4-b]pyrazines (1986-07-15),
4. 4511721 - Intermediate for preparing antifungal 1,2-dihydropyrido[3,4-b]-pyrazines (1985-04-16),
5. 4451650 - Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines (1984-05-29),
6. 4450160 - 1,2-Dihydropyrido[3,4-b]-pyrazines and method and intermediates for (1984-05-22),

Title: Glynn P Wheeler: Innovator in Anticancer Research

Introduction

Glynn P Wheeler is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of anticancer research, holding a total of 6 patents. His work focuses on developing innovative compounds that enhance cancer treatment efficacy.

Latest Patents

Wheeler's latest patents include a groundbreaking synergistic anticancer combination. This patent discloses a compound that, when combined with vincristine, produces synergistic antitumor activity. Another significant patent involves intermediates for preparing 1,2-dihydropyrido[3,4-b]pyrazines, which possess anticancer activity. These compounds are characterized by specific structural components that enhance their therapeutic potential.

Career Highlights

Glynn P Wheeler is affiliated with Southern Research Institute, where he continues to advance his research in cancer therapeutics. His innovative approaches have positioned him as a key figure in the development of new treatment options for cancer patients.

Collaborations

Wheeler has collaborated with esteemed colleagues, including Carroll G Temple, Jr and John A Montgomery. These partnerships have fostered a collaborative environment that enhances the research and development of anticancer therapies.

Conclusion

Glynn P Wheeler's contributions to anticancer research through his patents and collaborations highlight his commitment to improving cancer treatment. His innovative work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…